<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Assessment of late <z:chebi fb="0" ids="33375">gadolinium</z:chebi> enhancement (LGE) at cardiac magnetic resonance is often used to detect scar in patients with <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> of right ventricular (RV) origin </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, electroanatomic mapping (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>) has been shown to reliably detect scars corresponding to different cardiomyopathic substrates </plain></SENT>
<SENT sid="2" pm="."><plain>We compared LGE with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> for the detection of scar in patients with <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> of RV origin </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: Thirty-one patients with RV <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and biopsy-proven structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> (18 ARVC and 13 <z:mp ids='MP_0001856'>myocarditis</z:mp>), and 5 with idiopathic RV outflow tract <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> underwent LGE analysis and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> with scar validation through <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e>-guided endomyocardial biopsy </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> scars were present in 23 (64%) patients (<z:hpo ids='HP_0000001'>all</z:hpo> with structural <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e>), whereas LGE was present only in 12 (33%) </plain></SENT>
<SENT sid="5" pm="."><plain>In 2 cases, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> provided a false-positive diagnosis of a small scar in the basal perivalvular area </plain></SENT>
<SENT sid="6" pm="."><plain>LGE correctly diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> scar in 48% of patients, resulting in high positive (92%) but low negative (50%) predictive values </plain></SENT>
<SENT sid="7" pm="."><plain>The distribution of LGE was significantly associated with the distribution of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> scars (P &lt; 0.001 in the free wall, P = 0.003 in the outflow tract, and P = 0.023 in the posterior/inferior wall) </plain></SENT>
<SENT sid="8" pm="."><plain>Presence of LGE reflected a higher extension of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> scars (34.4 ± 16.5% vs 7.9 ± 10.1% of the RV area, P &lt; 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>At receiver operating characteristic (ROC) analysis, an extension of scar ≥20% of the RV area was the best cut-off value to detect LGE (sensitivity 83%, specificity 92%) </plain></SENT>
<SENT sid="10" pm="."><plain>Of note, LGE missed 10 of 11 (91%) patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> scars &lt;20% of RV area </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: LGE is significantly less sensitive than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> in identifying RV cardiomyopathic substrates </plain></SENT>
<SENT sid="12" pm="."><plain>Absence of LGE does not rule out the presence of small scars, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">EAM</z:e> with biopsy should be considered to increase the diagnostic yield </plain></SENT>
</text></document>